Verition Fund Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-22,700
Closed -$253K – 3935
2025
Q2
$253K Buy
+22,700
New +$281K ﹤0.01% 3274
2024
Q4
– Sell
-31,704
Closed -$495K – 3435
2024
Q3
$495K Buy
31,704
+4,112
+15% +$65.9K ﹤0.01% 2324
2024
Q2
$366K Buy
+27,592
New +$378K ﹤0.01% 2234
2024
Q1
– Sell
-10,050
Closed -$135K – 2913
2023
Q4
$135K Buy
+10,050
New +$118K ﹤0.01% 2113
2023
Q1
– Sell
-10,408
Closed -$214K – 2444
2022
Q4
$214K Buy
+10,408
New +$184K ﹤0.01% 1718
2017
Q1
– Sell
-6,436
Closed -$233K – 1381
2016
Q4
$233K Sell
6,436
-466
-7% -$17.7K 0.02% 962
2016
Q3
$295K Buy
6,902
+1,041
+18% +$46.5K 0.03% 794
2016
Q2
$249K Buy
+5,861
New +$255K 0.03% 670

Other funds holding OFIX

Verition Fund Management's OFIX Position: Q3 2025 in Review

Verition Fund Management sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 22,700 shares — an estimated $253K sold.

Verition Fund Management first reported a position in OFIX in Q2 2016 and held it in 8 quarters. The position peaked at $495K in Q3 2024. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Verition Fund Management reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 22,700 Orthofix Medical shares in Q3 2025, an estimated $253K.
  • Verition Fund Management first reported a position in Orthofix Medical in Q2 2016 and held it in 8 quarters.
  • Verition Fund Management's Orthofix Medical position peaked at $495K in Q3 2024.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.